1. Home
  2. LYRA vs YDKG Comparison

LYRA vs YDKG Comparison

Compare LYRA & YDKG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lyra Therapeutics Inc.

LYRA

Lyra Therapeutics Inc.

HOLD

Current Price

$3.97

Market Cap

7.6M

Sector

Health Care

ML Signal

HOLD

Logo Yueda Digital Holding Class A Ordinary Share

YDKG

Yueda Digital Holding Class A Ordinary Share

N/A

Current Price

$1.23

Market Cap

8.0M

ML Signal

N/A

Company Overview

Basic Information
Metric
LYRA
YDKG
Founded
2005
2005
Country
United States
China
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Advertising
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.6M
8.0M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
LYRA
YDKG
Price
$3.97
$1.23
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$16.00
N/A
AVG Volume (30 Days)
94.1K
1.3M
Earning Date
11-12-2025
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$600,000.00
$13,107,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$93.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2175.52
52 Week Low
$2.84
$0.99
52 Week High
$37.50
$669.00

Technical Indicators

Market Signals
Indicator
LYRA
YDKG
Relative Strength Index (RSI) 43.81 N/A
Support Level $3.93 N/A
Resistance Level $4.59 N/A
Average True Range (ATR) 0.43 0.00
MACD 0.20 0.00
Stochastic Oscillator 64.57 0.00

Price Performance

Historical Comparison
LYRA
YDKG

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

About YDKG Yueda Digital Holding Class A Ordinary Share

Yueda Digital Holding is a digital-economy company with a focus on the long-term accumulation of mainstream cryptocurrencies. The business activities of the company include active treasury management of mainstream digital assets, exploration of compliant, risk-managed yield opportunities, such as staking, on-chain liquidity provision, and other conservative market activities, selective investments and partnerships in Web3 infrastructure and applications, and advisory services for enterprises entering the digital-asset economy.

Share on Social Networks: